Additional file 6: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study

  • Cheng Maw Ho (Contributor)
  • Chih-hsin Lee (Contributor)
  • Ming-Chia Lee (Contributor)
  • Jun Fu Zhang (Contributor)
  • Jann Yuan Wang (Contributor)
  • Rey Heng Hu (Contributor)
  • Po-Huang Lee (Contributor)

Dataset

Description

Table S4. Effects of ACEI and ARB on the risk of HCC in different subgroups of HBV and HCV cohorts. (DOCX 22Â kb)
Date made availableApr 10 2018
PublisherUnknown Publisher

Cite this